rs200792578
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_206933.4(USH2A):c.12790G>A(p.Glu4264Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000768 in 1,614,064 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. E4264E) has been classified as Likely benign.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.12790G>A | p.Glu4264Lys | missense_variant | 63/72 | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.12790G>A | p.Glu4264Lys | missense_variant | 63/72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.12790G>A | p.Glu4264Lys | missense_variant | 63/73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000387 AC: 97AN: 250728Hom.: 1 AF XY: 0.000354 AC XY: 48AN XY: 135492
GnomAD4 exome AF: 0.0000670 AC: 98AN: 1461800Hom.: 1 Cov.: 37 AF XY: 0.0000633 AC XY: 46AN XY: 727192
GnomAD4 genome AF: 0.000171 AC: 26AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74456
ClinVar
Submissions by phenotype
Retinal dystrophy Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Dec 13, 2018 | - - |
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2020 | This variant is associated with the following publications: (PMID: 31054281, 30703234, 24938718) - |
Usher syndrome type 2A;C3151138:Retinitis pigmentosa 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Jan 19, 2017 | - - |
Usher syndrome type 2A Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 10, 2020 | - - |
USH2A-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 23, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at